CDL36
CDL36 is a BAX inhibitor with an EC50 of 23.6 µM. CDL36 inhibits pro-apoptotic peptide-induced mitochondrial outer membrane permeabilization (MOMP). CDL36 exerts cytoprotective effects against Doxorubicin (HY-15142A)-induced cell death.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 951529-42-3
- Formule: C29H32N6O2
- Masse moléculaire:496.60
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Protocole
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Description
IC50 & Target
[1]|
Bax 23.6 μM (EC50) |
In Vitro
CDL36 (12.5-25 µM; 72 h) specifically protects intact CRISPR control cells and BAX knockout (KO) A549 cells against 5 µM Doxorubicin (HY-15142A)-induced cell death over a 72-hour treatment period[1].
CDL36 binds to recombinant BAX protein as determined by microscale thermophoresis, with an EC50 of 23.6 µM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 951529-42-3
-
Masse moléculaire 496.60
-
Formule C29H32N6O2
-
SMILES
CN(C1=C2C=CC=C1)C=C2C3=NN(CCC4=O)C(N4CC(N(CC5)CCN5C6=CC=CC(C)=C6C)=O)=C3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
CDL36 Related Classifications
HY-187706 Related Classifications
Powered by Bioz